View Item 
        •   Utrecht University Student Theses Repository Home
        • UU Theses Repository
        • Theses
        • View Item
        •   Utrecht University Student Theses Repository Home
        • UU Theses Repository
        • Theses
        • View Item
        JavaScript is disabled for your browser. Some features of this site may not work without it.

        Browse

        All of UU Student Theses RepositoryBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

        Risk-Benefit Analysis in Clinical Research Guidelines, Practices and a Utilitarian Interpretation

        Thumbnail
        View/Open
        Reinout Kroes - thesis - 20AUG2012.pdf (359.8Kb)
        Publication date
        2012
        Author
        Kroes, R.P.
        Metadata
        Show full item record
        Summary
        This thesis explores several guidelines regarding risk-benefit analysis in clinical research, how some investigators apply these guidelines and concludes that lacunas in both guidance and practice can be observed. Risk-benefit analysis appears to be a difficult task in clinical research. Further, given its necessity for decision-making and its complexity in execution, this thesis explores how we must understand risk-benefit analysis. Because of its natural roots, a discussion is started to come to a utilitarian interpretation of risk-benefit analysis. Two modified features are articulated to meet the practice in clinical research. First, pain and pleasure from classical (hedonistic) utilitarianism are abandoned and replaced by Quality-Adjusted-Life-Years (QALYs). Second, a constraint on the maximum allowable risks is introduced in order to avoid participants from being sacrificed in experimentation. After having presented a most plausible version of a utilitarian interpretation of risk-benefit analysis, a substantial package of criticism remains. This criticism underpins the claim that risk-benefit analysis is a tool under development. If attention is given to some weak points of its procedure, risk-benefit analysis may support the balancing of potential harms and opportunities to some degree. However, it is undesirable to trust risk-benefit analysis as an indisputable calculation model commanding a decision in clinical experimentation by its own force.
        URI
        https://studenttheses.uu.nl/handle/20.500.12932/19144
        Collections
        • Theses
        Utrecht university logo